PDF
(Download)
|
- Saw Palmetto (Serenoa repens, Arecaceae)
- DNA Barcode Authentication
- Misidentification
|
Date:
03-13-2015 | HC# 101464-516
|
Re: Saw Palmetto DNA Mini-barcode Assay Developed to Distinguish between Authentic and Spurious Material in Dietary Supplements
Little
DP, Jeanson ML. DNA barcode authentication of saw palmetto herbal dietary
supplements. Sci Rep. December 17, 2013;3:3518. doi: 10.1038/srep03518.
Saw palmetto (Serenoa
repens, Arecaceae) grows in the southeastern United States and produces
edible fruits. Native American people used saw palmetto traditionally for the
treatment of gastrointestinal problems and as a diuretic.1 Saw
palmetto is currently used in the treatment of benign prostate hyperplasia;
clinical trials suggest its efficacy and safety.1 It is essential
that botanicals used as dietary supplements be definitively identified. DNA
barcoding is one way to confirm species identification. The genes matK and rbcL encode plastid proteins and are commonly used for DNA
barcoding in plants. This basic research study set out to produce a DNA barcode
library for the identification of saw palmetto, introduce an assay based on a
DNA barcode for saw palmetto identification, and test this assay on saw
palmetto supplements commercially available in the United States. Plant parts
in supplements were not described beyond being "dry, cut, and sifted plant
materials."
The matK (n=27) and
rbcL (n=37) barcode sequences were generated
from dried leaves of 37 identified specimens from several species. A
distinction between saw palmetto and the related species in the authenticated
leaf material was achieved by a combination in nucleotide differences in the
full-length matK and rbcL sequences. However, amplification
of full-length barcode sequences in the commercial dietary supplements using
polymerase chain reaction (PCR) did not work in this study due to fragmented
DNA. To circumvent this problem, the authors composed mini-barcode primers to
amplify specific nucleotide ranges of matK
and rbcL that could distinguish saw
palmetto from other species. The mini-barcodes were validated using the
authentic leaf specimens and tested on saw palmetto supplements. For validation,
13 samples of saw palmetto and 18 samples of a closely related species to saw
palmetto, the Paurotis palm (Everglades palm; Acoelorrhaphe wrightii, Arecaceae), were analyzed. All validation samples were correctly
identified using the combination of matK
and rbcL mini-barcodes. Specificity and sensitivity were both
1.00, with 95% confidence intervals of 0.74-1.00 and 0.66-1.00, respectively.
From a total of 37 saw palmetto supplements, 34
yielded amplifiable DNA. In 30 of the supplements, both matK and rbcL
mini-barcodes were successfully sequenced. In total, 29 supplements definitely
contained saw palmetto; the mini-barcode of rbcL
was unobtainable in three other supplements. Since the rbcL sequence allows distinction between saw palmetto and the
Paurotis palm, the authors were unable to determine whether they had saw
palmetto or Paurotis palm or both in these three products. Of the 34 supplements
where DNA could be obtained, two were found to be adulterated; one product contained
Paurotis palm, and one had another unidentifiable species.
In conclusion, the authors state that initial
failure of PCR in obtaining barcodes from dietary supplements is not unusual,
especially when handling longer regions of DNA. To get around this, the
mini-barcodes were devised and validated for identification of both specimens
and supplements of saw palmetto. It is speculated that the reasons for failing
to obtain DNA from three of the dietary supplements may be due to absence of
saw palmetto itself, degradation of DNA due to the processing, or inhibition of
sequencing during PCR. It is also surmised that the rbcL mini-barcode may be more sensitive to degradation than that of
matK.
Despite these technical limitations, if DNA from both
mini-barcode sequences is obtained, distinctive identification of saw palmetto
from even its closely related species, the Paurotis palm, is definitive. It is
concluded that conflicting results in clinical studies involving saw palmetto
supplements may be due, at least in part, to the use of adulterated products.
This study provides a robust method by which to determine the purity of saw
palmetto supplements, and it can be used to identify contamination of
supplements by additional species.
—Amy C. Keller, PhD
Reference
1Blumenthal M,
Goldberg A, Brinckmann J, eds. Herbal
Medicine: Expanded Commission E Monographs. Austin, TX: American Botanical Council; Newton, MA: Integrative
Medicine Communications; 2000.
|